Sumitomo will ramp up production of its Falken car and truck tires over the next three years as it continues to make Dunlop-brand motorcycle tires, which are popular on the racing circuit, as well as Dunlop tires sold to Japanese automakers. Its production of Goodyear tires will steadily wind down over the next two years as part of the companies' separation agreement.
Another company, Pine Pharmaceuticals, will also appear before the planning board Wednesday for confirmation of its final site plan approval for a $5.6 million drug compounding facility. The planning board gave the company a conditional approval last month, while it worked out an access agreement with TM Montante, owner of the Riverview Solar Technology Park at 355 Riverwalk Parkway.
"That's another fantastic project," said Hartz. "They are hiring many more people in the expansion and these are good paying jobs too - upwards of a $150,000 per year in high-tech, chem-lab positions. We are very happy they decided to locate in Tonawanda."
Pine Pharmaceutical, owned by Alfonse J. Muto, wants to construct the 25,000-square-foot building to house its offices, laboratory, manufacturing, warehousing and distribution operations. The business is a subsidiary of Pine Pharmacy, which is located Niagara Falls.
Muto, who founded Pine Pharmacy in 1985, started Pine Pharmaceuticals in 2013 with his son to make customized drugs that could be shipped directly to doctors, according to Erie County IDA documents. The company has outgrown its current space at 100 Colvin Woods Parkway in Tonawanda where it employs 19 people. It expects to add another 15 if the project is completed.
According to their ECIDA application officials hope to begin work by March 14 and finish by Sept. 28 with manufacturing expected to begin by Nov. 3.